In this Urology Times Special Report series, Mark D. Tyson II, MD, MPH discusses high-risk non–muscle invasive bladder cancer (NMIBC) with Alexandra Drakaki, MD.
How Academic Centers Coordinate High-Risk NMIBC Care
Advertisement
Advertisement
Trending on Urology Times
1
Initial prostate cancer presentation, family history linked to survival in mCRPC
2
State of Men’s Health Act: What urologists need to know
3
FDA greenlights phase 1 trial of ADI-212 in mCRPC
4
Nicole L. Miller, MD, FACS, on persistent LUTS after BPH treatment
5